Oxy Watchdog

Keeping An Eye On OxyContin

Posts Tagged ‘prescription monitoring program’

Makers of Oxy contribute to prescription monitoring programs

Posted by Oxy Watchdog on October 22, 2010

Purdue Pharma, makers of OxyContin, contributed $200,000 towards the support and implementation of prescription drug monitoring programs earlier this week, according to this article from News-Medical.net. The monies were contributed to the non-profit National Association of State Controlled Substances Authorities and will go toward grants which assist states to maintain prescription monitoring programs, the Association’s main focus. In the article, a Purdue representative states that the pharmaceutical company has been supporting appropriately-designed monitoring programs to help reduce the abuse and diversion of prescription drugs. According to the article, the Association will manage the funding of grants and Purdue will have no input in the final selection process. Though OxyContin abuse has skyrocketed in the U.S. and abroad, Purdue Pharma makes a reported $3 billion per year on the opiate painkiller.

Read more about prescription monitoring programs here.

Posted in Pharmaceutical Industry | Tagged: , , , , , , , , , , , , , , | 1 Comment »

Congress examines interstate prescription drug abuse

Posted by Oxy Watchdog on October 7, 2010

In the midst of an ever-growing prescription drug abuse epidemic in the U.S., a congressional caucus met late September to examine interstate cooperation of prescription monitoring programs to better prevent doctor shopping, reports this article form Wicked Local Watertown.

Massachusetts Senator Steven Tolman testified before the caucus about the importance of sharing prescription data among states. Tolman oversees a state in which opiates like heroin and OxyContin are now the leading cause of death for young people, causing nearly 15 such deaths per week.

“Oxy hijacks your brain,” Sen. Tolman told OxyWatchdog in a July 2010 interview. “It grabs you. And it’s $80 a pill versus $4 for a bag of heroin. It’s the worst thing I’ve ever seen, and it’s in every community.”

To read more about prescription drug abuse monitoring programs, go here.
Read about Mass. struggle with OxyContin here.

Posted in Policy & Regulation | Tagged: , , , , , , , , , , | 3 Comments »

Fla. doctors find few repercussions in fraudulent prescribing practices

Posted by Oxy Watchdog on October 3, 2010

More than a fourth of doctors in Florida found to have illegally prescribed medication are still practicing and prescribing without repercussions, reports this investigation by the St. Petersburg Times. The in-depth investigation found that the system for identifying and disciplining the doctors is slow and ineffective, doing little to curb a prescription drug abuse epidemic that kills seven Floridians per day. Though some of the doctors prescribed the drugs for illicit reasons, most were certified professionals taking advantage of the lucrative dealing. Whats more, the state’s prescription drug monitoring program that went into effect Oct. 1 leaves loopholes that do not address the trend.

Read about Florida’s prescription drug monitoring program here.
Information on pill-related overdoes in Florida can be found here.

Posted in Crime, Trends | Tagged: , , , , , , , , , , , , , , , , | 1 Comment »

Fla. drug monitoring program faces delay, criticism

Posted by Oxy Watchdog on September 16, 2010

Florida’s new prescription drug monitoring program may be put on hold due to a bid dispute despite the increasing rate of drug abuse in the state, reports this article in the St. Petersburg Times. One of the companies that lost out on the bid to create the program is now claiming the state health department’s selection process was unfair. What’s more, the program has already faced criticism over loopholes that could allow for doctor shopping. Florida is one of about 12 states in the U.S. without a prescription drug monitoring program, yet prescription drugs are now the number one cause of overdose in the state.

To read more about prescription drug monitoring programs in the U.S. from the Drug Enforcement Administration, go here.

Posted in Litigation, Policy & Regulation | Tagged: , , , , , , , | 2 Comments »

N.C. police push for open prescription records

Posted by Oxy Watchdog on September 7, 2010

An association of sheriffs in North Carolina wants to allow law enforcement officials full access to the state’s prescription monitoring program in a bid to curb doctor shopping and abuse of narcotics, reports an article in the Charlotte Observer. Patient advocates in the state argue that such a move would violate privacy and cause a chilling effect on necessary use of pain medication such as OxyContin. Though North Carolina’s Controlled Substance Reporting System mirrors that of other states and is open to doctors, pharmacists, and certain government agents, police cannot apply for access. A similar bill was challenged by the ACLU in 2007 due to privacy concerns, and as it stands, only 30 percent of the state’s doctors and pharmacies have registered to use the existing system.

In the first six months of this year, nearly 2.5 million people filled prescriptions for more than 375 million doses of controlled substances such as OxyContin – nearly a third of the state’s residents, the article says.

Posted in Litigation, Policy & Regulation | Tagged: , , , , | Leave a Comment »

Canada cracks down on highest narcotic usage in the world

Posted by Oxy Watchdog on August 28, 2010

Facing the highest per capita usage of narcotics in the world, and double the rate of abuse than the rest of the country, the province of Ontario, Canada is implementing a prescription drug monitoring program similar to those already in place in the U.S. Ontario has seen the use of prescription oxycodone increase 900 percent since 1991, claiming more deaths than HIV each year, reports the Winnipeg Free Press. According to a study published in the Canadian Medical Association Journal late last year, the death toll has increased dramatically since the new slow-release version of OxyContin hit the market—supposedly a version less prone to abuse.

To read more about the new version of slow-release OxyContin, go here.

Find out more about prescription drug monitoring programs in the U.S. here.

Posted in Litigation, Policy & Regulation, Trends | Tagged: , , , , , , , | Leave a Comment »

Strengthened Mass. law targets Oxy abuse

Posted by Oxy Watchdog on August 25, 2010

Through an updated electronic monitoring system, Mass. doctors will keep closer tabs on potential prescription drug abuse, including OxyContin–the abuse of which is a particular problem in the state. According to DOTmed News, the law will limit doctors prescribing unnecessary drugs, increases the number of drugs that are monitored, and report when patients are receiving the same prescription from multiple sources, among other changes. At least 9,000 Mass. residents are suspected of engaging in “doctor shopping” annually, reports the GovMonitor. According to the U.S. Drug Enforcement Administration, the state joins 34 others in the U.S. with existing prescription monitoring programs.

Decisions leading up to Mass. prescription monitoring program can be found here.

Reports on opiate abuse in Mass can be read here.

Read about Oregon’s implementation of the program here.

Posted in Litigation, Policy & Regulation, Trends | Tagged: , , , , | 1 Comment »

 
%d bloggers like this: